$27.62 0.00 (%) Qiagen NV - NASDAQ

Dec. 5, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Illumina Misses Revenue Forecast Causing Collateral Damage To Biotechs

    TalkMarkets | Oct. 11, 2016 | 23:00PM EST
  2. Illumina Plunges After Cutting Estimated Q3 Revenue View

    TalkMarkets | Oct. 11, 2016 | 16:38PM EST
  3. Biotech ETFs Lead Q3 Rally: XBI Breaks Out

    TalkMarkets | Sep. 22, 2016 | 20:00PM EST
  4. QIAGEN to Supply QuantiFERON-TB Tests to Ease Tuberculin Shortage

    Benzinga | Jan. 26, 2016 | 04:22AM EST
  5. Top Performing Industries For July 20, 2015

    Benzinga | Jul. 20, 2015 | 09:39AM EST
  6. Seegene and QIAGEN Enter Into a Collaboration to Develop Multiplex Molecular Diagnostic Assays

    GuruFocus | Jul. 8, 2015 | 23:03PM EST
  7. Seegene and QIAGEN Enter Into a Collaboration to Develop Multiplex Molecular Diagnostic Assays

    Benzinga | Jul. 8, 2015 | 15:00PM EST
  8. Illumina Falls On HiSeq Rival; Bio-Reference Up on Q2

    IBD | Jun. 8, 2015 | 11:31AM EST
  9. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 23, 2015 | 08:23AM EST
  10. US Stock Futures Signal Higher Start On Wall Street

    Benzinga | Jan. 12, 2015 | 07:14AM EST
  11. QIAGEN Announces First-ever Regulatory Registration of a Lung Cancer Companion Diagnostic Based on Liquid Biopsies in Collaboration With AstraZeneca

    Benzinga | Jan. 12, 2015 | 04:51AM EST
  12. Barclays Initiates Coverage On Life Science Tools & Diagnostics, Names Thermo Fisher As 'Top Pick'

    Benzinga | Jan. 7, 2015 | 16:41PM EST
  13. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 6, 2015 | 08:21AM EST
  14. Drugmaker AstraZeneca Returns To Growth

    IBD | Aug. 5, 2014 | 16:22PM EST
  15. Top 4 Stocks In The Research Services Industry With The Highest Profit Margin

    Benzinga | Aug. 1, 2014 | 04:16AM EST
  16. Top 4 NASDAQ Stocks In The Research Services Industry With The Highest EPS

    Benzinga | Jul. 18, 2014 | 03:36AM EST
  17. UPDATE: HSBC Upgrades Qiagen N.V. to Neutral

    Benzinga | May. 13, 2014 | 09:53AM EST
  18. Benzinga's Top Upgrades

    Benzinga | May. 13, 2014 | 06:53AM EST
  19. Top 4 NASDAQ Stocks In The Research Services Industry With The Highest Revenue

    Benzinga | Apr. 23, 2014 | 03:31AM EST
  20. Top 4 Stocks In The Research Services Industry With The Lowest PEG Ratio

    Benzinga | Mar. 27, 2014 | 03:30AM EST
  21. QIAGEN Announces European Launch of Therascreen IDH1/2Test for Gliomas

    Benzinga | Jan. 6, 2014 | 16:49PM EST
  22. Benzinga's Top #PreMarket Losers

    Benzinga | Nov. 25, 2013 | 08:20AM EST
  23. Benzinga's Top #PreMarket Losers

    Benzinga | Nov. 18, 2013 | 08:16AM EST
  24. QIAGEN Announces Agreement to Develop Molecular Companion Diagnostic Paired with Lilly Investigational Cancer Compounds

    Benzinga | Nov. 18, 2013 | 08:09AM EST
  25. Illumina Hits New High As HiSeq Yields Record Quarter

    IBD | Oct. 22, 2013 | 09:44AM EST
  26. QIAGEN Announces Partnership With Clovis Oncology to Co-develop Companion Diagnostic Targeting Drug-Resistant EGFR Mutations

    Benzinga | Oct. 21, 2013 | 15:02PM EST
  27. J&J Q3 Results: Strong In Pharma, So-So Elsewhere

    IBD | Oct. 15, 2013 | 16:54PM EST
  28. Disappointing Preliminary Earnings from Quest Diagnostics Trickles Down to Qiagen

    Benzinga | Oct. 10, 2013 | 13:23PM EST
  29. Top 4 Stocks In The Research Services Industry With The Highest Cash

    Benzinga | Jul. 24, 2012 | 21:49PM EST
  30. UPDATE: ISI Group Initiates Qiagen with Underweight, $15 PT on Muted BioPharma and Academic Segments

    Benzinga | Jul. 10, 2012 | 03:16AM EST
  31. Biotech Gets Personal: Long on Qiagen (QGEN) & SPDR S&P Biotech (XBI)

    GuruFocus | Feb. 29, 2012 | 11:23AM EST
  32. UPDATE: JP Morgan Upgrades Qiagen to Overweight

    Benzinga | Jan. 4, 2012 | 03:38AM EST
  33. JP Morgan Upgrades Qiagen to Overweight

    Benzinga | Jan. 3, 2012 | 23:51PM EST
Trading Center